New Horizons Diagnostic Corporation (NHD) develops, manufactures, and tests products for the detection of bacteria and toxins in human, environmental, surface, food, and water samples for government, municipal and corporate customers. It offers diverse medical products, such as products for testing cholera, gonorrhea, syphilis, and drug abuse screening products. The major product line for NHD is the development, marketing and sales of rapid antibody based diagnostic kits. Infectious diseases spread through food or water is a common, distressing, and sometimes life-threatening problem for millions of people in the United States and around the world. World Health Organization (WHO) studies have shown that in 1996, infectious and parasitic diseases accounted for 43% of the 40 million deaths in developing countries. The U.S. Centers for Disease Control and Prevention (CDC) estimates 76 million people suffer foodborne illnesses each year in the United States, accounting for 325,000 hospitalizations and more than 5,000 deaths.